BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11498254)

  • 1. In vitro evidence that immunuaffinity-purified MOG contains immunogenic quantities of contaminating mouse IgG; techniques for producing Ig-free MOG.
    Ohashi T; Yukitake M; Slavin A; Krieger J; Hafler DA
    J Neuroimmunol; 2001 Aug; 118(2):194-202. PubMed ID: 11498254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls.
    Van der Aa A; Hellings N; Bernard CC; Raus J; Stinissen P
    J Neuroimmunol; 2003 Apr; 137(1-2):164-76. PubMed ID: 12667661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
    Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
    Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
    Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
    Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG).
    Brehm U; Piddlesden SJ; Gardinier MV; Linington C
    J Neuroimmunol; 1999 Jun; 97(1-2):9-15. PubMed ID: 10408984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis.
    Karni A; Bakimer-Kleiner R; Abramsky O; Ben-Nun A
    Arch Neurol; 1999 Mar; 56(3):311-5. PubMed ID: 10190821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein.
    Lindert RB; Haase CG; Brehm U; Linington C; Wekerle H; Hohlfeld R
    Brain; 1999 Nov; 122 ( Pt 11)():2089-100. PubMed ID: 10545394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.
    Marta CB; Oliver AR; Sweet RA; Pfeiffer SE; Ruddle NH
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13992-7. PubMed ID: 16172404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human T cell response to myelin oligodendrocyte glycoprotein: a multiple sclerosis family-based study.
    Koehler NK; Genain CP; Giesser B; Hauser SL
    J Immunol; 2002 Jun; 168(11):5920-7. PubMed ID: 12023398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies directed against rubella virus induce demyelination in aggregating rat brain cell cultures.
    Besson Duvanel C; Honegger P; Matthieu JM
    J Neurosci Res; 2001 Sep; 65(5):446-54. PubMed ID: 11536329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis.
    Kennel De March A; De Bouwerie M; Kolopp-Sarda MN; Faure GC; Béné MC; Bernard CC
    J Neuroimmunol; 2003 Feb; 135(1-2):117-25. PubMed ID: 12576231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies.
    Abo S; Bernard CC; Webb M; Johns TG; Alafaci A; Ward LD; Simpson RJ; Kerlero de Rosbo N
    Biochem Mol Biol Int; 1993 Aug; 30(5):945-58. PubMed ID: 8220243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.
    Lalive PH; Menge T; Delarasse C; Della Gaspera B; Pham-Dinh D; Villoslada P; von Büdingen HC; Genain CP
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2280-5. PubMed ID: 16461459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis.
    Gaertner S; de Graaf KL; Greve B; Weissert R
    Neurology; 2004 Dec; 63(12):2381-3. PubMed ID: 15623705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls.
    Haase CG; Guggenmos J; Brehm U; Andersson M; Olsson T; Reindl M; Schneidewind JM; Zettl UK; Heidenreich F; Berger T; Wekerle H; Hohlfeld R; Linington C
    J Neuroimmunol; 2001 Mar; 114(1-2):220-5. PubMed ID: 11240035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls.
    Xiao BG; Linington C; Link H
    J Neuroimmunol; 1991 Feb; 31(2):91-6. PubMed ID: 1991822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations.
    Pittock SJ; Reindl M; Achenbach S; Berger T; Bruck W; Konig F; Morales Y; Lassmann H; Bryant S; Moore SB; Keegan BM; Lucchinetti CF
    Mult Scler; 2007 Jan; 13(1):7-16. PubMed ID: 17294606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
    Kerlero de Rosbo N; Hoffman M; Mendel I; Yust I; Kaye J; Bakimer R; Flechter S; Abramsky O; Milo R; Karni A; Ben-Nun A
    Eur J Immunol; 1997 Nov; 27(11):3059-69. PubMed ID: 9394837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.
    Egg R; Reindl M; Deisenhammer F; Linington C; Berger T
    Mult Scler; 2001 Oct; 7(5):285-9. PubMed ID: 11724443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.
    Weissert R; Kuhle J; de Graaf KL; Wienhold W; Herrmann MM; Müller C; Forsthuber TG; Wiesmüller KH; Melms A
    J Immunol; 2002 Jul; 169(1):548-56. PubMed ID: 12077287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.